Cargando…
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959889/ https://www.ncbi.nlm.nih.gov/pubmed/35356217 http://dx.doi.org/10.3389/fonc.2022.880458 |
| _version_ | 1784677262427160576 |
|---|---|
| author | Li, Zhaoqing Chen, Cong Chen, Lini Hu, Dengdi Yang, Xiqian Zhuo, Wenying Chen, Yongxia Yang, Jingjing Zhou, Yulu Mao, Misha Zhang, Xun Xu, Ling Ju, Siwei Shen, Jun Wang, Qinchuan Dong, Minjun Xie, Shuduo Wei, Qun Jia, Yunlu Zhou, Jichun Wang, Linbo |
| author_facet | Li, Zhaoqing Chen, Cong Chen, Lini Hu, Dengdi Yang, Xiqian Zhuo, Wenying Chen, Yongxia Yang, Jingjing Zhou, Yulu Mao, Misha Zhang, Xun Xu, Ling Ju, Siwei Shen, Jun Wang, Qinchuan Dong, Minjun Xie, Shuduo Wei, Qun Jia, Yunlu Zhou, Jichun Wang, Linbo |
| author_sort | Li, Zhaoqing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8959889 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89598892022-03-29 Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 Li, Zhaoqing Chen, Cong Chen, Lini Hu, Dengdi Yang, Xiqian Zhuo, Wenying Chen, Yongxia Yang, Jingjing Zhou, Yulu Mao, Misha Zhang, Xun Xu, Ling Ju, Siwei Shen, Jun Wang, Qinchuan Dong, Minjun Xie, Shuduo Wei, Qun Jia, Yunlu Zhou, Jichun Wang, Linbo Front Oncol Oncology Frontiers Media S.A. 2022-03-09 /pmc/articles/PMC8959889/ /pubmed/35356217 http://dx.doi.org/10.3389/fonc.2022.880458 Text en Copyright © 2022 Li, Chen, Chen, Hu, Yang, Zhuo, Chen, Yang, Zhou, Mao, Zhang, Xu, Ju, Shen, Wang, Dong, Xie, Wei, Jia, Zhou and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Li, Zhaoqing Chen, Cong Chen, Lini Hu, Dengdi Yang, Xiqian Zhuo, Wenying Chen, Yongxia Yang, Jingjing Zhou, Yulu Mao, Misha Zhang, Xun Xu, Ling Ju, Siwei Shen, Jun Wang, Qinchuan Dong, Minjun Xie, Shuduo Wei, Qun Jia, Yunlu Zhou, Jichun Wang, Linbo Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
| title | Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
| title_full | Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
| title_fullStr | Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
| title_full_unstemmed | Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
| title_short | Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1 |
| title_sort | corrigendum: stat5a confers doxorubicin resistance to breast cancer by regulating abcb1 |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959889/ https://www.ncbi.nlm.nih.gov/pubmed/35356217 http://dx.doi.org/10.3389/fonc.2022.880458 |
| work_keys_str_mv | AT lizhaoqing corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT chencong corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT chenlini corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT hudengdi corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT yangxiqian corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT zhuowenying corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT chenyongxia corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT yangjingjing corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT zhouyulu corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT maomisha corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT zhangxun corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT xuling corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT jusiwei corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT shenjun corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT wangqinchuan corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT dongminjun corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT xieshuduo corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT weiqun corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT jiayunlu corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT zhoujichun corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 AT wanglinbo corrigendumstat5aconfersdoxorubicinresistancetobreastcancerbyregulatingabcb1 |